Host serine proteases: a potential targeted therapy for COVID-19 and influenza
Y Rahbar Saadat, SM Hosseiniyan Khatibi… - Frontiers in Molecular …, 2021 - frontiersin.org
The ongoing pandemic illustrates limited therapeutic options for controlling SARS-CoV-2
infections, calling a need for additional therapeutic targets. The viral spike S glycoprotein …
infections, calling a need for additional therapeutic targets. The viral spike S glycoprotein …
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2–21 years …
Children and adolescents form a large proportion of societies and play an important role in
the transmission of COVID-19. On the other hand, their education, mental and physical …
the transmission of COVID-19. On the other hand, their education, mental and physical …
Factors predicting readmission in patients with COVID-19
M Nematshahi, D Soroosh, M Neamatshahi… - BMC research …, 2021 - Springer
Objective COVID-19 has been introduced by the World Health Organization as a health
emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 …
emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 …
[PDF][PDF] Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir …
V Mitev - Pharmacia, 2023 - pharmacia.pensoft.net
Millions of publications and thousands of clinical trials have not led to the discovery of an
effective treatment for COVID-19. We believe that the reason for this is the inaccurate …
effective treatment for COVID-19. We believe that the reason for this is the inaccurate …
Effect of bromhexine in hospitalized patients with COVID-19
R Tolouian, ZD Mulla, H Jamaati… - Journal of …, 2023 - journals.sagepub.com
Background: Bromhexine is a potent inhibitor of transmembrane serine protease 2 and
appears to have an antiviral effect in controlling influenza and parainfluenza infection; …
appears to have an antiviral effect in controlling influenza and parainfluenza infection; …
Indomethacin: can it counteract bradykinin effects in COVID-19 patients?
M Alkotaji, RN Al-Zidan - Current Pharmacology Reports, 2021 - Springer
COVID-19 represents the biggest health challenge. Although the mortality rate of COVID-19
is low, the high numbers of infected people and those with post-COVID-19 symptoms …
is low, the high numbers of infected people and those with post-COVID-19 symptoms …
[HTML][HTML] The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran
S Kalantari, A Sadeghzadeh-Bazargan… - Medical Journal of the …, 2021 - ncbi.nlm.nih.gov
Background: The COVID-19 infection is a novel virus that mainly targets the respiratory
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …
Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province
N Gharebaghi, S Farshid, B Boroofeh… - … Journal of Clinical …, 2021 - Wiley Online Library
Background COVID‐19 is considered a widespread concern in global public health.
Diagnoses of COVID‐19 in some cases are necessary because of severe prognosis. In this …
Diagnoses of COVID‐19 in some cases are necessary because of severe prognosis. In this …
Identifying factors related to mortality of hospitalized COVID-19 patients using machine learning methods
F Hamidi, H Hamishehkar, PPA Markid, P Sarbakhsh - Heliyon, 2024 - cell.com
Background The COVID-19 pandemic has had a profound impact globally, presenting
significant social and economic challenges. This study aims to explore the factors affecting …
significant social and economic challenges. This study aims to explore the factors affecting …
Demand for Psychiatrist Nurse in the COVID-19 Inpatient Wards
R Khezri, R Valizadeh, P Nozad, Z Maleki… - Journal of Health …, 2022 - jhsss.sums.ac.ir
In December 2019, the viral outbreak was reported in Wuhan, China, by a novel virus
named COVID-19 1, 2. The virus spread worldwide rapidly because of its high …
named COVID-19 1, 2. The virus spread worldwide rapidly because of its high …